COMMUNIQUÉS West-GlobeNewswire

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
23/07/2026
New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization [...]
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
23/07/2026
Company has addressed final review items from penetration testing and finalized cybersecurity and software documentation 510(k) package submission on track for calendar H2 2026, targeting planned entry into multi- [...]
First American Equipment Finance renews HFMA Peer Review designation
23/07/2026
CHICAGO, July 23, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, First American Equipment Finance has once again achieved the “Peer [...]
Indulge Sonoma Returns for an Unforgettable Celebration of Sonoma County's Culinary Excellence
23/07/2026
SANTA ROSA, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Indulge Sonoma, Sonoma County's premier culinary and beverage festival, returns Saturday, September 12, 2026, bringing together the region's finest restaurants, [...]
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
23/07/2026
WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays
23/07/2026
Tarrytown, New York, USA, July 23, 2026 (GLOBE NEWSWIRE) -- Capillary testing is a patient-friendly option and ideal for difficult veins Capillary capability helps scale core labs’ testing offerings easily using [...]
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
23/07/2026
CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will [...]
Precision Neuroscience™ Appoints John Donoghue, Pioneer of Brain–Computer Interfaces, as Scientific Advisor
23/07/2026
The scientist whose lab produced the first proof that a paralyzed person could control devices with thought joins Precision to help bring its technology to market NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Precision [...]
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
23/07/2026
Agreement Temporarily Restricts Preferred-to-Common Stock Conversions Below a Defined Price Threshold, Mitigating Potential Near-Term Dilution GAITHERSBURG, Md., July 23, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. ( [...]
Cato Supply Rebrands as Cato Healthcare Supply to Reflect Expanded Mission of Protecting Hospital Revenue Through Supply Chain Resilience
23/07/2026
DALLAS, July 23, 2026 (GLOBE NEWSWIRE) -- Cato Supply Inc. today announced its official rebrand to Cato Healthcare Supply , a strategic evolution that better reflects the company's mission. Cato stands for Completely [...]
Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026
23/07/2026
SALT LAKE CITY, July 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings conference call at 4: [...]
University of Iowa and Stride Autism Centers Partner on OSERS-Funded ICORE Project to Develop the Next Generation of Behavior Analysts
23/07/2026
Five-year initiative pairs rigorous academic preparation at the University of Iowa with intensive clinical supervision at Stride Autism Centers — building the workforce of Board Certified Behavior Analysts that Iowa [...]
ApolloMD Earns National and Atlanta Best and Brightest Companies to Work For® Honors for Second Straight Year
23/07/2026
ATLANTA, July 23, 2026 (GLOBE NEWSWIRE) -- ApolloMD has been named one of the 2026 Best and Brightest Companies to Work For ® both nationally and in Atlanta for the second consecutive year, recognizing continued [...]
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
23/07/2026
Dr. Ascheim has over 30 years of clinical and executive experience advancing breakthrough therapies, including gene, cell, and biologics MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) a clinical [...]
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
23/07/2026
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE [...]
IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development
23/07/2026
Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights IMNN-001 as one of the [...]
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
23/07/2026
CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]
Aeroflow Health’s Independent Research Identifies Why Mothers Miss Postpartum Care and What Health Plans Can Do About It
23/07/2026
Aeroflow’s research provides health plans with key insights into why new mothers miss the vital six-week postpartum visit ASHEVILLE, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a technology-enabled [...]

Pages